Wednesday, 7 December 2011

Atorvastatin+Amlodipine (Caudet): Ranbaxy launched authorized generic

The generic player Ranbaxy has launched the authorized generic version of Amlodipine+ Atorvastatin (Caudet) tablets in US market. This was confirmed by the generic pharma giant in following press release: http://www.ranbaxy.com/news/newsdisp.aspx?cp=988&flag=LN

Innovator Pfizer is currently marketing about 11 combination strenghts in US market (Amlodipine+Atorvastatin):

10+10, 10+20, 10+40, 10+80, 2.5+10, 2.5+20, 2.5+40, 5+10, 5+20, 5+40, 5+80 mg tablets

This launch was as per Ranbaxy's earlier settlement with innovator Pfizer. Earlier, Ranbaxy has challenged the innovator's combination patent on this combination US6455574, scheduled to expire on Aug 11, 2018.

No comments:

web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
 
eXTReMe Tracker